click below
click below
Normal Size Small Size show me how
Basic Pharmacology
| Term | Definition |
|---|---|
| Absorption | the process of a drug taken into the body moving from the site of administration into the blood. |
| Adverse Effect | the undesired and potentially harmful side effects of medications. Examples include: nausea, vomiting and hypersensitivity. |
| Agonist | drugs that are attracted or bond to a receptor and cause a particular response. Example: acetylocholine |
| Antagonists | type of drugs that prevent or inhibit a response; receptor blockers. |
| Bioavailability | how the drug molecule reaches to the target site to exert its effects. |
| Biotechnology | using the concepts of genetic engineering and recombinant DNA technology to create drugs. |
| Biotransformation | the process of changing lipid-soluble drug molecules into water-soluble molecules for excretion. Commonly occurs in the liver. |
| Bolus | given all at once. |
| Contraindication | reasons or situations where a drug should not be given or used. |
| Distribution | the process where the circulatory system transports the drug throughout the body and drug molecules diffuse in the bloodstream. |
| Duration | time between onset of a drug and its disappearance. |
| Emulsion | type of liquid; a mixture of oil and water bound together with an emulsifier. |
| Enteral | route of administration; drug taken into the GI tract primarily orally. |
| Excretion | the process of drug molecules leaving the body; via bile, feces, skin, and urine. |
| Hypersensitivity | an adverse effect from previous exposure to the drug; symptoms can range from mild to severe. |
| Idiosyncratic effect | when the reason behind an adverse reaction is unknown; rare and unpredictable. |
| Indication | the purpose of giving a medication. |
| Local effect | where the medication works at the site of application. |
| Onset | time between administration and and first appearance of effect. |
| Parenteral | any route of administration except the GI tract; examples include; topical, subcutaneous, IV. |
| Pharmacodynamics | the study how drugs affect the body. |
| Pharmacokinetics | the study of how the body processes drugs; absorption, distribution, biotransformation, excretion. |
| Plasma protein binding | drug molecules that bind to proteins in blood plasma, usually nonspecific and competitive. |
| Reconstituted | powdered medications that must be mixed with liquid to form a solution prior to administration. |
| Side effect | predictable but unintended effect of a drug. |
| Solubility | the ability of a drug to dissolve. |
| Solution | the mixture of drug molecules in a solvent. |
| Suspension | undissolved drug particles floating in a liquid. |
| Synergist | a drug that enhances the effect of another drug. |
| Systemic effect | the effect of a drug through out the entire body. |
| Topical | route of administration; applied directly to target site. |
| Controlled substances | certain medications; scheduled into five classes and enforced by the DEA; the Controlled Substance Act was passed in 1970. |
| Narcotics | when administered hospitals must keep records of amount used, date, patient, who administered the medication, and who obtained the medication. |
| DEA | Drug Enforcement Administration; established to enforce the Controlled Substance Act. |
| FDA | Food and Drug Administration; inspects drug facilities, receives new drug applications, investigates and removes harmful drugs, requires proper labeling; developed the classification system related to medication effects on unborn fetuses. |
| The Joint Commission | nonprofit organization that evaluates and accredits health care organizations and programs. |
| OTC | non-prescribed medications; Over the Counter medications. |
| PDR | Physician's Desk Reference; the most frequently used pharmacology resource. |
| USP-NF | United States Pharmacopeia and National Formulalry; the official medication list recognized by U.S. government. |